Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1366 results for "life sciences"

2,425 images for life sciences

PharmaVOICE, 2 hours ago
PharmaVOICE, 6 hours ago
Mideast Time, 1 week ago
WorldNetDaily, 10 hours ago
Yahoo! Singapore, 10 hours ago
The Bubble, 10 hours ago
Business Link, 4 days ago
American Banking News - Forex, 1 week ago
MyNewsDesk, 1 day ago
BizReport.com, 4 days ago

Buy Jubilant Life, IIFL Holdings; sell Tata Elxsi: Gujral

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Jubilant Life Sciences and IIFL Holdings and sell Tata Elxsi.
 Money Control16 hours ago
Financial Express

Top buzzers: Gammon Infra, Indo Count, Vama Ind, Jubilant Life

Share price of Jubilant Life Sciences touched a 52-week high of Rs 519.50, gains 3 percent intraday Wednesday as it has received ANDA approval for Telmisartan tablets.
 Money Control6 days ago This Brazilian Footballer Has Rs 604 Crores Net Worth and This Is How He Spends His Money  Daily Bhaskar1 week ago Jubilant Life surges over 50% in 7 days. Here's why  MSN India1 week ago Jubilant Life Sciences extends rally post Q1 results  Business Standard1 week ago
[x]  

Jubilant Life Sciences scales record high

Jubilant Life Sciences gained 3.73% to Rs 525.95 at 11:45 IST on BSE after the company announced that it has received final approval for abbreviated new drug application for Felodipine Extended-Release Tablets from the US drug regulator.
 Business Standard5 days ago Jubilant Life Sciences gains after receiving USFDA approval for drug  Business Standard6 days ago Jubilant Life Sciences surges on strong Q1 results  Smart Investor2 weeks ago Jubilant Life Sciences surges 9% after strong Q1 results  Myiris2 weeks ago
First Post.com

Stocks in focus: Jubilant Life, AstraZeneca, Tata Global, Welspun, Monsanto India

Jubilant Life Sciences stock today surged nearly 8 per cent after it received final approval from the US health regulator to sell tablets used in the treatment of hypertension in the American market. The scrip gained 7.81 per cent to Rs 546.70 its 52-week ...
 Business Line5 days ago Jubilant Life gets USFDA nod for hypertension tablets  Business Standard6 days ago Jubilant Life jumps 8% on USFDA nod for hypertension tablets  Business Standard5 days ago Jubilant Life receives USFDA nod for hypertension tablets  First Post.com6 days ago

'Mars had favourable climate for life 4 billion years ago'

Scientists found fossilised riverbeds on Mars, making them think the planet would've supported life long ago.
 DNA6 days ago Mars had climate suitable for life four billion years ago  Zee News6 days ago
Money Control

Vyome Biosciences closes US$14mn Series C Financing

This financing round was led by Perceptive Advisors, a leading New York-based life sciences fund and, Romulus Capital, a Boston-based venture capital firm, along with participation from existing investors including Kalaari Capital, Sabre Partners and Aarin ...
 India Infoline1 week ago Vyome Biosciences raises $19 mn led by Perceptive Advisors  Money Control1 week ago Vyome Biosciences raises USD 19 mn led by Perceptive Advisors  Business Standard1 week ago Vyome Biosciences raises $14 mn led by Perceptive Advisors  Money Control1 week ago
Tech2

NASA readying OSIRIS-REx to find clues about the origins of life

NASA scientists are putting the finishing touches on a spacecraft designed to rendezvous with Asteroid Bennu in 2018 to find clues about the origins of life. The post NASA readying OSIRIS-REx to find clues about the origins of life appeared first on Tech2 .
 Tech21 week ago What are the origins of life? There's a rocket for that  Reuters1 week ago NASA's $1 billion OSIRIS-REx mission to find the origins of life  DNA1 week ago NASA To Launch Spacecraft To Near-Earth Asteroid  Silicon India1 month ago

Scientists to unveil new Earth-like planet: report

The planet, orbiting Proxima Centauri, has a favourable orbital range for water and life on its surface.
 DNA2 weeks ago Scientists find Earth-like planet circling sun's nearest neighbor  DNA5 days ago
India Infoline

Jubilant Life Sciences gets ANDA approval for Telmisartan Tablets

The company has announced that it has received ANDA final approval for Telmisartan Tablets the generic version of Micardis Tablets of Boehringer Ingelheim Pharmaceuticals Inc., which is used for the treatment of hypertension.
 India Infoline6 days ago Jubilant Life Sciences receives ANDA approval for Telmisartan tablets  Money Control6 days ago Jubilant Life Sciences advances after getting ANDA approval for Levetiracetam  Business Standard2 months ago Jubilant Life Sciences gets ANDA nod for Levetiracetam Injection USP  India Infoline2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - life sciences
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less